Humedix Co., Ltd.
200670.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$284.78B
Close$
Share Statistics
| Market cap | $284.78 Billion |
|---|---|
| Enterprise Value | $239.47 Billion |
| Dividend Yield | $1170.00 (4.56%) |
| Earnings per Share | $5017 |
| Beta | 0.34 |
| Outstanding Shares | 11,074,000 |
Return
| Return on Equity | 14.90% |
|---|---|
| Return on Assets | 13.72% |
| Return on Invested Capital | 13.05% |
Valuation & Multiples
| P/E Ratio | 6.78 |
|---|---|
| PEG | -9.84 |
| Price to Sales | 1.6 |
| Price to Book Ratio | 0.92 |
| Enterprise Value to Revenue | 1.35 |
| Enterprise Value to EBIT | 5.91 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$1219.00
Average shareholder expectationRevenue Estimate
$46.20 B
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$51.30 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Humedix Co., Ltd.
377 employees
CEO: Min-jong Kang Humedix Co., Ltd. is a South Korean healthcare enterprise engaged in the research, development, production, and distribution of a diverse array of pharmaceutical goods. Its comprehensive portfolio encompasses non-prescription and prescri...